Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Summary

This research is studying the preventative use of topical 0.1% tazarotene gel daily in addition to best practice standards to reduce the development of hand-foot skin reaction (HFSR).

Timeline

Start

2019-12-30

Primary completion

2021-06-12

Completion

2022-07-14

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty with patient recruitment”

Drugs

Indications